Columbia Wanger Asset Management’s MacroGenics MGNX Stock Holding History

Columbia Wanger Asset Management’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$7.79M	Buy	+410,002	New	+$7.65M	0.12%	195

Other funds holding MGNX

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Columbia Wanger Asset Management's MGNX Position: Q4 2017 in Review

Columbia Wanger Asset Management opened a new position in MacroGenics (MGNX) in Q4 2017: 410,002 shares worth $7.79M. The stake represents 0.12% of the portfolio and ranks #195 among its holdings.

119 funds tracked by Wall St. Rank hold MGNX as of Q4 2017.

Columbia Wanger Asset Management held 410,002 shares of MacroGenics worth $7.79M as of Q4 2017.
MacroGenics was a new Columbia Wanger Asset Management position in Q4 2017.
MacroGenics made up 0.12% of Columbia Wanger Asset Management's portfolio in Q4 2017, its #195 holding.
119 funds tracked by Wall St. Rank held MacroGenics as of Q4 2017.

Based on Columbia Wanger Asset Management's 13F filing for Q4 2017, filed 13 Feb 2018.